Education
About Us
Working with TipRanks
Follow Us
Kissei Pharmaceutical Co Ltd (KSPHF)
OTHER OTC:KSPHF
RESEARCH TOOLSreports
Total Valuation
Kissei Pharmaceutical Co has a market cap or net worth of $1.22B. The enterprise value is $115.09B.
Market Cap$1.22B
Enterprise Value$115.09B
Share Statistics
Kissei Pharmaceutical Co has 47,911,186 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,911,186
Owned by Insiders―
Owned by Institutions0.18%
Financial Efficiency
Kissei Pharmaceutical Co’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 1.94%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)1.94%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee49.65M
Profits Per Employee6.72M
Employee Count1,779
Asset Turnover0.36
Inventory Turnover1.77
Valuation Ratios
The current PE Ratio of Kissei Pharmaceutical Co is 14.02. Kissei Pharmaceutical Co’s PEG ratio is 1.75.
PE Ratio14.02
PS Ratio0.00
PB Ratio0.71
Price to Fair Value0.80
Price to FCF-44.68
Price to Operating Cash Flow-93.51
PEG Ratio1.75
Income Statement
In the last 12 months, Kissei Pharmaceutical Co had revenue of 88.33B and earned 11.96B in profits. Earnings per share was 274.20.
Revenue88.33B
Gross Profit44.06B
Operating Income5.77B
Pretax Income15.61B
Net Income11.96B
EBITDA20.25B
Earnings Per Share (EPS)274.20
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Kissei Pharmaceutical Co pays an annual dividend of $0.31, resulting in a dividend yield of 2.44%
Dividend Per Share$0.31
Dividend Yield2.44%
Payout Ratio16.41%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.04
52-Week Price Change37.16%
50-Day Moving Average24.00
200-Day Moving Average24.03
Relative Strength Index (RSI)97.66
Average Volume (3m)3.00
Important Dates
Kissei Pharmaceutical Co upcoming earnings date is Aug 4, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 4, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
Kissei Pharmaceutical Co as a current ratio of 6.45, with Debt / Equity ratio of 0.61%
Current Ratio6.45
Quick Ratio4.95
Debt to Market Cap<0.01
Net Debt to EBITDA-1.18
Interest Coverage Ratio274.95
Taxes
In the past 12 months, Kissei Pharmaceutical Co has paid 3.63B in taxes.
Income Tax3.63B
Effective Tax Rate0.23
Enterprise Valuation
Kissei Pharmaceutical Co EV to EBITDA ratio is 7.10, with an EV/FCF ratio of 71.42.
EV to Sales1.63
EV to EBITDA7.10
EV to Free Cash Flow71.42
EV to Operating Cash Flow22.06
Balance Sheet
Kissei Pharmaceutical Co has $44.46B in cash and marketable securities with ¥1.28B in debt, giving a net cash position of -$43.18B billion.
Cash & Marketable Securities$44.46B
Total Debt¥1.28B
Net Cash-$43.18B
Net Cash Per Share-$901.25
Tangible Book Value Per Share$4.77K
Margins
Gross margin is 49.41%, with operating margin of 6.54%, and net profit margin of 13.54%.
Gross Margin49.41%
Operating Margin6.54%
Pretax Margin17.67%
Net Profit Margin13.54%
EBITDA Margin22.93%
EBIT Margin17.70%
Analyst Forecast
The average price target for Kissei Pharmaceutical Co is $34.13, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$34.13
Price Target Upside25.80% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―